Tratamiento farmacológico en la deshabituación tabáquica. Ventajas e inconvenientes de los tratamientos actuales / Advantages and drawbacks of current pharmacological treatments for smoking cessation
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. impr.)
; 38(8): 505-510, nov.-dic. 2012.
Article
in Spanish
| IBECS
| ID: ibc-106841
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
Actualmente disponemos de 3 familias de fármacos que son los que se utilizan habitualmente en la práctica clínica y que ayudan a los fumadores a dejar de serlo la terapia sustitutiva con nicotina, bupropión y vareniclina. El conocimiento resumido de las particularidades, eficacia y contraindicaciones de cada uno de ellos nos puede resultar útil para realizar una prescripción adecuada a nuestros pacientes (AU)
ABSTRACT
There are currently three families of drugs that are commonly used in the clinic to help smokers to stop; nicotine replacement therapy, bupropion and varenicline. Summary knowledge of the specific efficacy and contraindications of each of them can be useful before prescribing them to our patients (AU)
Search on Google
Collection:
National databases
/
Spain
Health context:
SDG3 - Target 3A Strengthen the implementation of the WHO Framework Convention on Tobacco Control
/
SDG3 - Health and Well-Being
Health problem:
Protection from Exposure
/
Tobacco Dependence and Cessation
/
Target 3.5: Prevention and treatment of consumption of psychoactive substances
Database:
IBECS
Main subject:
Smoking
/
Smoking Cessation
/
Tobacco Use Cessation
/
Tobacco Use Cessation Devices
Limits:
Female
/
Humans
/
Male
Language:
Spanish
Journal:
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. impr.)
Year:
2012
Document type:
Article
Institution/Affiliation country:
Universidad Católica de Murcia/España